Infection with M. genitalium may double African women's HIV risk
A common sexually transmitted bacterial infection more than doubles the risk of HIV infection in African women, reports a study in the March issue of AIDS.
View ArticleCommon sexually transmitted bacterial infection more than doubles risk of HIV
A common sexually transmitted bacterial infection more than doubles the risk of HIV infection in African women, according to a study by researchers at RTI International.
View ArticleStudy reveals how HSV-1 virus overcomes intrinsic host defenses
New biological research reveals how an invading virus hijacks a cell's workings by imitating a signaling marker to defeat the body's defenses. By manipulating cell signals, the virus destroys a...
View ArticleAbbott receives CE Marking for PLEX-ID instrument and assays
Abbott announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system:...
View ArticleAllied Healthcare announces Coridon license to vector technology
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines....
View ArticleScientists discover tumor-targeting neural stem cells
Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research...
View ArticleMaternal antiviral suppressive therapy may not be as effective as thought
Maternal antiviral suppressive therapy does not necessarily prevent the development of neonatal herpes simplex virus disease, warn researchers in The Journal of Pediatrics.
View ArticleA new strategy to prevent herpes virus infections
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes...
View ArticlePain, itching associated with shingles may be due to virus causing "short...
The pain and itching associated with shingles and herpes may be due to the virus causing a "short circuit" in the nerve cells that reach the skin, Princeton researchers have found.
View ArticleHIV risk-reduction counseling at time of HIV testing shows no reduction in...
Brief risk-reduction counseling at the time of a rapid human immunodeficiency virus (HIV) test was not effective for reducing new sexually transmitted infections (STIs) during the subsequent 6 months...
View ArticlePopulation Council gets USAID cooperative agreement to develop non-ARV...
The Population Council today announced it was awarded a cooperative agreement from the US Agency for International Development's (USAID) Office of HIV and AIDS: "Non-ARV Based Combination Microbicide...
View ArticleAgenus reports net loss attributable to common stockholders of $5.8 million...
Agenus Inc., a biopharmaceutical company developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced its...
View ArticleScientists develop microbicide gel that prevents transmission of multiple...
Population Council scientists and their partners have found that their proprietary microbicide gel is safe, stable, and can prevent the transmission of multiple sexually transmitted infections (STIs)...
View ArticleNanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone...
NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014.
View ArticleInfection with herpes simplex virus increases Alzheimer's risk
Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University, Sweden, claim this in two studies in the journal Alzheimer's & Dementia.
View ArticleChemotherapy drug combined with cancer-killing virus may treat recurrent...
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent.
View ArticleStudy reports effective treatment approach to inhibit herpes virus infection
A multi-institutional study reports an effective treatment approach to inhibit and keep latent viruses like herpes simplex from reactivating and causing disease. The work, whose lead author is the late...
View ArticleSLU investigators find promising candidates for new herpes virus treatments
Saint Louis University research findings published in the December issue of Antimicrobial Agents and Chemotherapy report a family of molecules known as nucleotidyltransferase superfamily (NTS) enzyme...
View ArticleJohns Hopkins researchers successfully deliver new nanoparticle gene therapy...
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations...
View ArticleNew type of vaccine holds promise for prevention of genital herpes
Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes--one of the most common sexually...
View Article
